Liisa Maattanen

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.

Postscreening follow-up of the Finnish Prostate Cancer Screening Trial on putative prostate cancer risk factors: vitamin and mineral use, male pattern baldness, pubertal development and non-steroidal anti-inflammatory drug use.

Journal: Scandinavian journal of urology

Published: March 02, 2016

Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Statin Use and Prostate Cancer Survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Journal: European urology focus

Published: February 15, 2016

Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial.

Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial.

Journal: Cancer causes & control : CCC

Published: April 23, 2015

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC.

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC.

Journal: British journal of cancer

Published: April 02, 2015

Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.

Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the Finnish prostate cancer screening trial.

Journal: The Prostate

Published: January 08, 2015

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Journal: Lancet (London, England)

Published: August 11, 2014

The Finnish prostate cancer screening trial: analyses on the screening failures.

The Finnish prostate cancer screening trial: analyses on the screening failures.

Journal: International journal of cancer

Published: June 02, 2014

Family history in the Finnish Prostate Cancer Screening Trial.

Family history in the Finnish Prostate Cancer Screening Trial.

Journal: International journal of cancer

Published: April 28, 2014

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial.

Journal: British journal of cancer

Published: March 16, 2014

Effects of prostate cancer screening on health-related quality of life: results of the Finnish arm of the European randomized screening trial (ERSPC).

Effects of prostate cancer screening on health-related quality of life: results of the Finnish arm of the European randomized screening trial (ERSPC).

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 22, 2013

Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.

Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.

Journal: BJU international

Published: June 11, 2013

Prostate cancer mortality in the Finnish randomized screening trial.

Prostate cancer mortality in the Finnish randomized screening trial.

Journal: Journal of the National Cancer Institute

Published: March 13, 2013

Showing 1-12 of 15

Last Updated: 09/26/2026